Join to View Full Profile
The University of Texas MD Anderson Cancer Center1515 Holcombe BlvdHouston, TX 77030
Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Medical Oncology, 2019 - 2021
University of Utah HealthResidency, Internal Medicine, 2016 - 2019
University of Tennessee Health Science Center College of MedicineClass of 2015
Certifications & Licensure
TX State Medical License 2020 - 2027
UT State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC.Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, Lianchun Xiao, Nazli Dizman
The Oncologist. 2025-04-04 - 2 citationsClinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, Zita D Lim, Priya Rao
European Urology Oncology. 2025-04-01 - Body composition in recurrent prostate cancer and the role of steroidogenic genotype.Neha Venkatesh, Rebecca S Tidwell, Yao Yu, Ana Aparicio, Amado J Zurita
Endocrine-Related Cancer. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
